Do Acellular Mucin Pools in Resection Margins for Rectal Cancer Influence Outcomes?

  • Parag Ingle
  • Munita Bal
  • Reena Engineer
  • Vikas Ostwal
  • Ashwin Desouza
  • Avanish SaklaniEmail author
Original Article


Positive resection margins predict poor prognosis in rectal cancer (RC). Literature on the impact of acellular mucin (ACM) in circumferential resection margin (CRM) or distal resection margin (DRM) of proctectomy specimens on RC recurrence and outcomes is lacking. The retrospective study was conducted to determine the oncological outcomes of the RC patients with ACM in or within 1 mm of margins of the rectal resection specimens. Histopathology reports of RC resection specimens dated from June 2013 till May 2016 were reviewed to identify cases with ACM in CRM (n = 10) and DRM (n = 2). Relevant details of these patients were gathered from the electronic medical record. Pattern of recurrence was studied. In cases with only ACM in CRM (n = 10), disease (primary tumor or nodes) was radiologically reaching the mesorectal fascia except two, who had extra mesorectal nodes. Median distance of tumor from anal verge was 2 cm. All patient received neoadjuvant therapy: four patients received chemoradiotherapy (NACTRT), one received short-course radiotherapy, and five received NACTRT followed by neoadjuvant chemotherapy. Abdominoperineal resection, intersphincteric resection and total pelvic exenteration were done for six, three, and one patient, respectively. In two additional cases of anterior resection with ACM in DRM, one underwent upfront resection while the other received NACTRT. Over a mean follow-up period of 43 months, four patients developed recurrences. Two of them had local recurrence and only one had isolated local recurrence. ACM in resection margins of RC resection specimens does not seem to increase likelihood of local recurrence.


Rectal cancer Mucin Resection margin Cancer recurrence 



  1. 1.
    Washington MK, Berlin J, Branton P et al (2009) Protocol for the examination of specimens from patients with primary carcinoma of the colon and rectum. Arch Pathol Lab Med 133(10):1539–1551Google Scholar
  2. 2.
    Shia J, McManus M, Guillem JG et al (2011) Significance of acellular mucin pools in rectal carcinoma after neoadjuvant chemoradiotherapy. Am J Surg Pathol 35(1):127–134CrossRefGoogle Scholar
  3. 3.
    de Campos-Lobato LF, Dietz DW, Stocchi L et al (2012) Clinical implications of acellular mucin pools in resected rectal cancer with pathological complete response to neoadjuvant chemoradiation. Colorectal Dis 14(1):62–67CrossRefGoogle Scholar
  4. 4.
    Lim SB, Hong SM, Yu CS, Hong YS, Kim TW, Park JH, Kim JH, Kim JC (2013) Prevalence and clinical significance of acellular mucin in locally advanced rectal cancer patients showing pathologic complete response to preoperative chemoradiotherapy. Am J Surg Pathol 2013 37:47–52CrossRefGoogle Scholar
  5. 5.
    Dworak O, Keilholz L, Hoffmann A (1997) (1997) pathological features of rectal cancer after preoperative radiochemotherapy. Int J Color Dis 12:19–23CrossRefGoogle Scholar
  6. 6.
    Nagtegaal I, Gaspar C, Marijnen C, van de Velde C, Fodde R, van Krieken H (2004) Morphological changes in tumour type after radiotherapy are accompanied by changes in gene expression profile but not in clinical behaviour. J Pathol 204:183–192CrossRefGoogle Scholar
  7. 7.
    Nagtegaal ID, Marijnen CA, Kranenbarg EK et al (2002) Short-term preoperative radiotherapy interferes with the determination of pathological parameters in rectal cancer. J Pathol 197:20–27CrossRefGoogle Scholar
  8. 8.
    Bernstein TE, Endreseth BH, Romundstad P, Wibe A, Norwegian Colorectal Cancer Group (2009) Circumferential resection margin as a prognostic factor in rectal cancer. Br J Surg 96(11):1348–1357CrossRefGoogle Scholar
  9. 9.
    Nagtegaal ID, Quirke P (2008) What is the role for the circumferential margin in the modern treatment of rectal cancer? J Clin Oncol 26(2):303–312CrossRefGoogle Scholar
  10. 10.
    Ostwal V, Engineer R, Ramaswamy A et al (2016) Surgical outcomes of post chemoradiotherapy unresectable locally advanced rectal cancers improve with interim chemotherapy, is FOLFIRINOX better than CAPOX? J Gastrointest Oncol 7(6):958–967CrossRefGoogle Scholar
  11. 11.
    Sauer R, Liersch T, Merkel S, Fietkau et al (2012) Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow-up of 11 years. J Clin Oncol 30(16):1926–1933CrossRefGoogle Scholar
  12. 12.
    Yeo SG, Kim MJ, Kim DY et al (2013) Patterns of failure in patients with locally advanced rectal cancer receiving pre-operative or post-operative chemoradiotherapy. Radiat Oncol 8(1):114CrossRefGoogle Scholar
  13. 13.
    Zeng W-G, Liang J-W, Wang Z, Zhang XM, Hu JJ, Hou HR, Zhou HT, Zhou ZX (2015) Clinical parameters predicting pathologic complete response following neoadjuvant chemoradiotherapy for rectal cancer. Chinese J Cancer 34:41CrossRefGoogle Scholar
  14. 14.
    Gurzu S, Bara T, Bara T Jr et al (2014) Clinical significance of carcinoembryonic antigen expression of acellular mucin pools after preoperative chemoradiotherapy of rectal carcinoma. Cancer Biother Radiopharm 29(7):295–297CrossRefGoogle Scholar

Copyright information

© Indian Association of Surgical Oncology 2019

Authors and Affiliations

  • Parag Ingle
    • 1
  • Munita Bal
    • 2
  • Reena Engineer
    • 3
  • Vikas Ostwal
    • 4
  • Ashwin Desouza
    • 5
  • Avanish Saklani
    • 5
    • 6
    Email author
  1. 1.Department of Surgical OncologyTata Memorial CentreMumbaiIndia
  2. 2.Department of Surgical PathologyTata Memorial CentreMumbaiIndia
  3. 3.Department of RadiotherapyTata Memorial CentreMumbaiIndia
  4. 4.Department of Medical OncologyTata Memorial CentreMumbaiIndia
  5. 5.Department of Colorectal Surgical OncologyTata Memorial CentreMumbaiIndia
  6. 6.Department of Gastrointestinal Surgery and Colorectal Surgical OncologyTata Memorial CentreMumbaiIndia

Personalised recommendations